MARASCA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.342
AS - Asia 11.088
EU - Europa 10.635
SA - Sud America 1.455
AF - Africa 141
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 19
Totale 50.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.071
GB - Regno Unito 4.339
HK - Hong Kong 3.523
CN - Cina 3.038
SG - Singapore 2.566
IT - Italia 1.661
SE - Svezia 1.215
BR - Brasile 1.200
DE - Germania 972
VN - Vietnam 576
RU - Federazione Russa 564
UA - Ucraina 499
TR - Turchia 403
FI - Finlandia 390
KR - Corea 224
BG - Bulgaria 210
FR - Francia 201
ID - Indonesia 185
IN - India 161
CA - Canada 157
AR - Argentina 93
NL - Olanda 82
IE - Irlanda 76
JP - Giappone 72
BD - Bangladesh 68
ES - Italia 68
MX - Messico 59
PL - Polonia 56
CZ - Repubblica Ceca 51
BE - Belgio 50
EC - Ecuador 50
ZA - Sudafrica 50
AT - Austria 46
AU - Australia 41
IQ - Iraq 36
LT - Lituania 35
PK - Pakistan 31
CL - Cile 30
MY - Malesia 27
IR - Iran 24
MA - Marocco 22
CO - Colombia 20
AE - Emirati Arabi Uniti 19
BZ - Belize 19
VE - Venezuela 19
RO - Romania 18
UZ - Uzbekistan 18
EG - Egitto 16
EU - Europa 15
PY - Paraguay 15
AZ - Azerbaigian 13
SA - Arabia Saudita 13
IL - Israele 12
SK - Slovacchia (Repubblica Slovacca) 12
CH - Svizzera 11
KE - Kenya 11
PE - Perù 10
PH - Filippine 10
TN - Tunisia 10
DZ - Algeria 9
SI - Slovenia 9
BO - Bolivia 8
DK - Danimarca 8
GR - Grecia 8
JM - Giamaica 8
RS - Serbia 8
UY - Uruguay 8
NP - Nepal 7
TW - Taiwan 7
AL - Albania 6
KG - Kirghizistan 6
LB - Libano 6
LK - Sri Lanka 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
PT - Portogallo 6
HN - Honduras 5
JO - Giordania 5
MK - Macedonia 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
ET - Etiopia 4
KZ - Kazakistan 4
MD - Moldavia 4
NG - Nigeria 4
BY - Bielorussia 3
HU - Ungheria 3
KW - Kuwait 3
LU - Lussemburgo 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GA - Gabon 2
Totale 50.684
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.510
Fairfield 3.248
Southend 3.187
Ashburn 2.444
Santa Clara 2.295
Woodbridge 1.877
Ann Arbor 1.651
Singapore 1.610
Houston 1.482
Chandler 1.447
Seattle 1.254
Wilmington 1.068
Cambridge 1.017
Hefei 983
Jacksonville 975
Dearborn 838
Nyköping 746
London 631
Beijing 495
Los Angeles 473
Modena 417
Chicago 415
New York 332
San Diego 301
Princeton 247
Buffalo 232
Izmir 227
Seoul 216
Sofia 207
Ho Chi Minh City 194
Eugene 189
Munich 183
Helsinki 181
Salt Lake City 174
Moscow 157
Jakarta 150
The Dalles 142
Shanghai 120
Milan 119
Council Bluffs 118
Fremont 112
Hanoi 101
Dallas 100
São Paulo 93
Bremen 90
Tampa 90
Bologna 83
Elk Grove Village 79
Redwood City 79
Columbus 75
Dublin 72
Rome 68
Boardman 66
Phoenix 66
Frankfurt am Main 64
Des Moines 63
San Jose 60
Dong Ket 57
Tokyo 56
Brussels 49
Falls Church 49
Toronto 49
Nuremberg 48
Brooklyn 47
Guangzhou 46
Atlanta 45
Lancaster 45
Montreal 44
Norwalk 43
Warsaw 43
Kent 41
Kunming 36
Rio de Janeiro 36
Orem 35
Denver 34
Stockholm 33
Turku 33
Brno 32
Miami 32
Kilburn 31
Nanjing 30
Philadelphia 30
Redondo Beach 29
Chennai 28
Dulles 28
San Francisco 28
Boston 27
Poplar 27
Reggio Emilia 27
Vienna 27
Parma 26
Belo Horizonte 25
Jinan 25
Johannesburg 25
Sterling 25
Albuquerque 24
Haiphong 24
Las Vegas 24
San Mateo 24
Melbourne 23
Totale 38.403
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 779
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 558
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 527
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 382
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 380
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 364
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 362
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 354
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 342
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 337
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 333
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 331
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 327
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 326
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 323
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 319
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 317
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 311
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 308
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 305
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 303
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 296
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 295
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 292
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 289
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 288
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 287
Mucorales-specific T cells in patients with hematologic malignancies 285
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 283
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 283
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 281
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 279
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 278
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 278
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience 278
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 278
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 276
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 275
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 272
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 271
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 270
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 269
The genetics of nodal marginal zone lymphoma 267
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 266
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 265
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance 265
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage 262
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 262
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 260
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 260
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 259
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 259
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 256
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 256
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia 253
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 253
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 252
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 252
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia 252
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 251
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 251
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 250
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 250
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 249
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 249
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 248
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 248
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 246
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 245
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 245
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 245
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia 244
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 242
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 239
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 238
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 238
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 237
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. 237
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 236
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. 235
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 234
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 234
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 233
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 233
P53 GENE POINT MUTATIONS IN RELATION TO P53 NUCLEAR-PROTEIN ACCUMULATION IN COLORECTAL CANCERS 232
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 232
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 232
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 231
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 231
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 229
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 229
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 229
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 228
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 227
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 227
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 227
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene 227
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction 227
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 227
Gestational thrombocytopenia - Reply 226
Totale 27.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.200 0 0 0 0 0 480 367 674 244 676 397 362
2021/20224.275 197 548 517 206 99 235 259 192 398 307 698 619
2022/20234.255 503 482 325 374 579 570 81 445 488 51 190 167
2023/20242.972 104 162 172 272 562 270 349 452 54 68 188 319
2024/202510.787 313 123 141 682 1.580 1.278 624 450 2.867 445 985 1.299
2025/20269.506 1.227 1.274 1.683 2.054 2.619 649 0 0 0 0 0 0
Totale 51.247